Cascadian Therapeutics Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

CASC 1.14 0.00 (0.00%)
price chart
Stock Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Receives ONT-380 ...
Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic breast cancer has received Fast Track designation from the U.S. Food and Drug ...
Cascadian boosted by FDA fast track for cancer drug  Proactive Investors USA & Canada
Cascadian's lead product candidate Fast Track'd for subtype of ...  Seeking Alpha
Oncothyreon (ONTY) Changes Name to Cascadian Therapeutics; Will Begin Trading ...
Oncothyreon Inc. (Nasdaq: ONTY) (Nasdaq: CASC) announced that the Company is changing its name to Cascadian Therapeutics, Inc. and will trade on the NASDAQ Global Select Market under the new ticker symbol “CASC,” effective at market open on ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) Will Begin Trading Under New Name ...  Journal Transcript
Oncothyreon Renames Itself Cascadian Therapeutics (NASDAQ:ONTY)  Sonoran Weekly Review
Biotech Beat: Analysts Weigh In On EXACT Sciences Corporation (EXAS ...
Exact shares rallied yesterday on an apparent leaked JAMA article unveiling that USPSTF highly recommends colon cancer screening from age 50 to 75, but will no longer rank tests; instead, it is providing a list of acceptable ones that includes FITDNA ...
BRIEF-Oncothyreon says company is changing its name to Cascadian Therapeutics
June 8 (Reuters) -. * Oncothyreon Inc says company is changing its name to cascadian therapeutics, inc. * Oncothyreon Inc says will trade on nasdaq global select market under new ticker symbol "CASC," effective at market open on June 9, 2016 Source ...
Stocks Inside Traders Spotlight: Cascadian Therapeutics Inc (USA (NASDAQ:CASC ...
Cascadian Therapeutics Inc (USA (NASDAQ:CASC) went higher by +0.73% to close at $ 0.95. The company exchanged total volume of 676.67 thousand shares throughout course of last trade however it holds an average trading capacity of 1.13 million ...
Cascadian Therapeutics Inc. (CASC): Billionaire Seth Klarman's Baupost Group ...
Billionaire Seth Klarman's Baupost Group recently reported a new stake in Cascadian Therapeutics Inc. (NASDAQ:CASC), in a 13G filing with the SEC.
Seth Klarman Buys —5 Million Shares of Cascadian Therapeutics  GuruFocus.com
Cascadian Therapeutics Says New Data Support Advancement of ONT-380 Study ...
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) has declined 65.00% since November 5, 2015 and is downtrending. It has underperformed by 64.01% the S&P500.
Friday Stock's Trend: Cascadian Therapeutics Inc (USA) (NASDAQ:CASC), SPX ...
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) went lower by -3.4109% to close at $ 0.9175. The company exchanged total volume of 9.86 million shares throughout course of last trade however it holds an average trading capacity of 1.11 million shares ...
Cascadian Therapeutics Incorporated (NASDAQ:CASC) Shorted Shares Decreased By ...
The short interest to Cascadian Therapeutics Incorporated's float is 10.99%. The stock increased 3.48% or $0.04 on July 15, hitting $1.19.
Cascadian Therapeutics Reports Topline ONT-380 "Triplet" Data and Outlines Key ...
SEATTLE, June 14, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, will present clinical data from the Company's ongoing Phase 1b studies, including updated clinical data from the study of ONT ...